Cystic fibrosis discovery

Scientists have developed a formulation that increases the delivery of a novel “antivirulence” agent to the lungs to manage cystic fibrosis A new rat study presented at the International Pharmaceutical Federation’s Pharmaceutical Sciences World Congress means health stakeholders are a step closer to better treatment for the condition, say researchers. About 80% of cystic fibrosis

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous EBOS to acquire HPS
Next Pharmacists without borders